.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Farmers Insurance
Baxter
Moodys
Daiichi Sankyo
Express Scripts
US Department of Justice
Fuji
Citi
Healthtrust

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021994

« Back to Dashboard
NDA 021994 describes TRAVATAN Z, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the TRAVATAN Z profile page.

The generic ingredient in TRAVATAN Z is travoprost. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the travoprost profile page.

Summary for NDA: 021994

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 021994

Ingredient-typeProstaglandins

Suppliers and Packaging for NDA: 021994

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC 021994 NDA Alcon Laboratories, Inc 0065-0260 0065-0260-02 1 BOTTLE in 1 CARTON (0065-0260-02) > 2.5 mL in 1 BOTTLE
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC 021994 NDA Alcon Laboratories, Inc 0065-0260 0065-0260-05 1 BOTTLE in 1 CARTON (0065-0260-05) > 5 mL in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.004%
Approval Date:Sep 21, 2006TE:ATRLD:Yes
Patent:8,268,299Patent Expiration:Oct 13, 2029Product Flag?YSubstance Flag?Delist Request?
Patent:8,323,630Patent Expiration:Sep 20, 2027Product Flag?YSubstance Flag?Delist Request?
Patent:8,388,941Patent Expiration:Sep 20, 2027Product Flag?YSubstance Flag?Delist Request?

Expired Orange Book Patents for NDA: 021994

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC021994-001Sep 21, 20066,849,253► Subscribe
Novartis Pharms Corp
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC021994-001Sep 21, 20065,510,383► Subscribe
Novartis Pharms Corp
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC021994-001Sep 21, 20066,503,497► Subscribe
Novartis Pharms Corp
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC021994-001Sep 21, 20065,889,052► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Covington
Citi
Johnson and Johnson
Teva
Farmers Insurance
Dow
Chubb
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot